Toshiba Lands Significant National Cooperative Contract
@ToshibaBusiness Awarded cooperative contract with Region 4, available through OMNIA Partners! Agreement provides K-12 schools, universities, nonprofit and government organizations affordable pricing on Toshiba products and services. #TeamToshiba
Share
This cooperative contract enables OMNIA Partners' members to benefit from rigorously negotiated pricing on Toshiba's award-winning products and services. This means OMNIA Partners members continue receiving volume pricing on Toshiba's innovative e-STUDIO ™ multifunction printers, managed print services, label and receipt printers, digital signage and Elevate Sky ® solutions.
Rigorous Vetting Process
Cooperative Contracts available through OMNIA Partners are competitively solicited and publicly awarded with cost-optimized vendor agreements. This makes it easier for participating members to select from carefully vetted vendors delivering products and services meeting the specific needs of school districts, universities, government and nonprofit organizations across the United States.
"It's our privilege to work alongside OMNIA Partners for 12 years now to help their members affordably accomplish their day-to-day goals through the use of our products and services," states Toshiba America Business Solutions Chief Revenue Officer Steven Sauer. "Our team is very much looking forward to continuing to address the constantly evolving technology needs OMNIA Partners members are seeking."
Click-to-Tweet: Toshiba Lands Significant National Cooperative Contract
About OMNIA Partners
As your ally in the purchasing process, OMNIA Partners is dedicated to optimizing procurement for your organization. Our goal is to improve the way your organization identifies, evaluates, and procures what they need at the best value. With free membership, you'll gain full access to our portfolio of leading national supplier contracts, spend visibility, analytics, and subject matter experts. Join thousands of members who are discovering a better way to buy. Visit www.omniapartners.com
About Toshiba America Business Solutions, Inc.
Toshiba America Business Solutions is a leading innovator of solutions empowering people to perform efficiently and effectively in their work environment. Serving professionals across the United States, Mexico, and Central and South America, Toshiba delivers secure and sustainable systems, services, and subscriptions to better print, manage, and display information. Toshiba continuously focuses on its clients and communities, is committed to sustainability, and is recognized as a Wall Street Journal Top 100 Sustainable Company. To learn more, please visit business.toshiba.com. Follow Toshiba on LinkedIn, X (Twitter) and YouTube.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Currax Expands Access to FDA-Approved Obesity Treatment with Brand Name Contrave® with New Cash Price Available via GoodRx
New cash pay program offers Contrave, the #1 branded oral non-GLP-1 weight loss medication brand, for as low as $199 per month* BRENTWOOD, Tenn., July 15, 2025 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax"), a specialty biopharmaceutical company and manufacturer of the #1 branded oral non-GLP-1 weight loss medication brand CONTRAVE® (naltrexone HCl/bupropion HCl), announces today the launch of its latest cost saving initiative with GoodRx, the leading platform for medication savings in the U.S. The national access program introduces a cash pay prescription offer for Contrave, expanding access to affordable weight management medication for more patients, regardless of insurance. According to the CDC, more than 40% of U.S. adults are living with obesity, yet cost and coverage barriers often limit access to effective treatment options. Now, patients can access Contrave at a cash price of $199 via GoodRx, regardless of insurance status, allowing them to fill their Contrave prescription at over 70,000 pharmacies across the United States. Through the program, millions of U.S. adults living with obesity and weight-related health issues will have access to obesity treatment. "At Currax, we truly believe in access for all and putting patients at the center of everything we do," said George Hampton, CEO of Currax Pharmaceuticals. "By making our cash price available through GoodRx, we are continuing to reduce barriers and provide an easy path for patients to get the treatment they need to manage their weight and improve their overall health." Obesity is one of the most pressing health challenges in the U.S., yet many people still struggle to access effective treatment. By combining Currax's clinical leadership in obesity care with GoodRx's reach and reputation for affordability, this collaboration removes a major barrier for patients who may not otherwise have access to FDA-approved medications. Together, the two companies are helping more people take control of their health with greater confidence and fewer hurdles. "Though millions of Americans struggle with obesity, weight management medications can be cost-prohibitive—with or without insurance—causing many people to delay or abandon prescribed treatments. These types of access and affordability challenges are why many pharmaceutical companies partner with GoodRx to reduce friction," said Dorothy Gemmell, Chief Commercial Officer at GoodRx. "By working with Currax to help consumers save money on Contrave, we're helping close this gap and delivering a simple affordability solution that improves access to a life-changing medication." Contrave is an FDA-approved, prescription-only oral medication for adults with obesity or those who are overweight with weight-related medical problems, used as an adjunct to a reduced-calorie diet and increased physical activity. For more information or to access the GoodRx Contrave savings card, visit: *Program benefit maximums and eligibility restrictions may apply. About CurraxCurrax Pharmaceuticals LLC is a specialty pharmaceutical business focused on addressing the #1 and #2 causes of preventable death in the United States, smoking and obesity. Currax distributes a range of both branded and generic pharmaceutical products, including CONTRAVE® (naltrexone HCl/bupropion HCl), ONZETRA® Xsail® (sumatriptan nasal powder), Silenor® (doxepin), Treximet®, (sumatriptan/naproxen sodium), and the authorized generic of Treximet®. For more information, please visit About CONTRAVE: CONTRAVE®, is an extended-release fixed dose combination of naltrexone and bupropion (naltrexone HCL/bupropion HCL) indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 or greater (obese), or adults with a BMI of 27 kg/m2 or greater (overweight) with at least one weight-related medical problem such as high blood pressure, high cholesterol, or type 2 diabetes. For full Prescribing Information, including BOXED Warning and Medication Guide, please go to Media Contactcurrax@ View original content to download multimedia: SOURCE Currax Pharmaceuticals LLC Melden Sie sich an, um Ihr Portfolio aufzurufen.
Business Wire
an hour ago
- Business Wire
IASA Opens Call for Content for 2026 Annual Conference
MALVERN, Pa.--(BUSINESS WIRE)-- IASA has officially opened its Call for Content for the 2026 IASA Xchange™ annual conference, taking place June 7–9, 2026, in New Orleans. Industry professionals are invited to submit session proposals that will shape the educational programming for the event. 'Speaking at IASA Xchange is a powerful opportunity to position yourself as a thought leader, share valuable insights, and contribute to the advancement of the insurance industry." Share IASA Xchange™ is the premier event for insurance professionals in accounting, finance, risk and technology, offering three days of forward-thinking educational sessions, dynamic speakers, an exhibition tradeshow and high-value networking opportunities. The 2026 event is expected to draw more than 500 attendees. The 2026 agenda will feature 30+ breakout sessions across key focus areas, including: Accounting and Finance Enterprise Risk Management Professional Development Technology Executive Education Session proposals may be submitted by those intending to present or by a colleague. Proposals should include a session title and description, 2–3 learning objectives, and at least one confirmed speaker. Examples of high-interest topics include: Tax, auditing, investing, National Association for Insurance Commissioners (NAIC) and more Cybersecurity and data security Workforce trends and succession planning Specific use-cases of AI in insurance Geopolitical risk and economic forecasts A full list of topics and submission requirements are available at The submission deadline is Aug. 31, 2025, and speaker acceptances will be announced in fall 2025. 'Speaking at IASA Xchange is a powerful opportunity to position yourself as a thought leader, share valuable insights, and contribute to the advancement of the insurance industry,' said IASA's Executive Director, Kim Nicholl-Keane. 'As the premier annual event serving a unique segment of insurance, Xchange consistently attracts a highly engaged audience eager to learn, connect and return year after year.' About IASA Xchange™ IASA's annual signature event attracts an estimated 500 members and industry partners each year. The conference is filled with CPE-eligible content, inspiring keynote speakers, workshops, social events, networking, and a tradeshow, in addition to IASA business and ceremonial meetings. IASA Xchange™ 2026 will be held June 7–9, in New Orleans. About IASA For nearly 100 years, the Insurance Accounting & Systems Association (IASA) has been the trusted source of knowledge and education connecting the community of insurance professionals in accounting, finance, systems, and technology. With over 500 insurance carriers and solution providers representing over 12,000 professionals, IASA membership encompasses diverse functions within the insurance field all with a core focus on COMMUNITY, EDUCATION and CONNECTION. IASA is a 501(c)(3) non-profit organization featuring 18 local chapters and national events such as our annual IASA Xchange conference and tradeshow. About The Institutes The Institutes® are a not-for-profit comprised of diverse affiliates that educate, elevate, and connect people in the essential disciplines of risk management and insurance. Through products and services offered by The Institutes nearly 20 affiliated business units, people and organizations are empowered to help those in need with a focus on understanding, predicting, and preventing losses to create a more resilient world. The Institutes is a registered trademark of The Institutes. All rights reserved.
Yahoo
an hour ago
- Yahoo
PG&E Achieves 42% Reduction in Methane Emissions, Surpassing 2025 Goal
OAKLAND, Calif., July 15, 2025 /PRNewswire/ -- Pacific Gas and Electric Company (PG&E) submitted a report to the California Public Utilities Commission reporting a 42 percent reduction of methane emissions in 2024 from its gas pipeline system compared to a 2015 baseline, surpassing its commitment to achieve a 20 percent reduction by 2025. In 2017, the CPUC and California Air Resources Board (CARB) directed PG&E to achieve a 20 percent emissions reduction below 2015 baseline levels by 2025. The company outpaced this goal and voluntarily set a target to achieve a 45 percent reduction by 2030. In June of this year, PG&E submitted its annual 2024 emissions data to the CPUC, which outlined the methodology and comprehensive approach the company took to achieve the 42 percent emission reduction, including: Enhancing the leak survey program that now assesses more than 42,000 miles of natural gas distribution pipeline every three years versus the previous five year rotation. Applying advanced leak detection technologies and utilizing an accelerated repair schedule for the largest emissions findings, also known as the PG&E Super Emitter Program. Continuing strategic implementation of gas mitigation technologies for planned ventings on transmission pipelines, compressor stations and underground storage. "Achieving and surpassing our methane emissions reduction goal is an important milestone that highlights our efforts to reduce the carbon footprint of our natural gas pipeline system. Coupled with our ongoing commitment to support the interconnection and delivery of California-produced renewable natural gas, we remain committed to achieving a net zero emissions energy system for our customers and hometowns," said Gas Engineering Vice President Austin Hastings. PG&E's Climate Strategy Report outlines the company's commitment to achieve a net zero emissions energy system by 2040 and a "climate positive" system by 2050. About PG&E Pacific Gas and Electric Company, a subsidiary of PG&E Corporation (NYSE:PCG), is a combined natural gas and electric utility serving more than 16 million people across 70,000 square miles in Northern and Central California. For more information, visit and View original content to download multimedia: SOURCE Pacific Gas and Electric Company Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
